These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27562210)

  • 1. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture.
    Sepúlveda-Crespo D; Jiménez JL; Gómez R; De La Mata FJ; Majano PL; Muñoz-Fernández MÁ; Gastaminza P
    Nanomedicine; 2017 Jan; 13(1):49-58. PubMed ID: 27562210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.
    Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramirez R; Jiménez JL; Muñoz-Fernández MA
    J Nanobiotechnology; 2021 Mar; 19(1):65. PubMed ID: 33658029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins.
    Li X; Li J; Feng Y; Cai H; Li YP; Peng T
    Antiviral Res; 2020 May; 177():104734. PubMed ID: 32057770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1.
    Vacas-Córdoba E; Maly M; De la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():1281-94. PubMed ID: 27103798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
    Ramirez S; Mikkelsen LS; Gottwein JM; Bukh J
    Gastroenterology; 2016 Nov; 151(5):973-985.e2. PubMed ID: 27453546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonate-ended carbosilane dendrimers with a flexible scaffold cause inactivation of HIV-1 virions and gp120 shedding.
    Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MA
    Nanoscale; 2018 May; 10(19):8998-9011. PubMed ID: 29726564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
    Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
    Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
    Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype.
    Frey A; Piras-Straub K; Walker A; Timm J; Gerken G; Herzer K
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29111569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection.
    Moreno S; Sepúlveda-Crespo D; de la Mata FJ; Gómez R; Muñoz-Fernández MÁ
    Antiviral Res; 2017 Oct; 146():54-64. PubMed ID: 28827122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy.
    Sepúlveda-Crespo D; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine; 2015 Aug; 11(6):1481-98. PubMed ID: 25835558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.
    Briz V; Sepúlveda-Crespo D; Diniz AR; Borrego P; Rodes B; de la Mata FJ; Gómez R; Taveira N; Muñoz-Fernández MÁ
    Nanoscale; 2015 Sep; 7(35):14669-83. PubMed ID: 26274532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.
    Sepúlveda-Crespo D; Lorente R; Leal M; Gómez R; De la Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine; 2014 Apr; 10(3):609-18. PubMed ID: 24135563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
    Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
    Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
    Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
    Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
    J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
    Córdoba EV; Arnáiz E; De La Mata FJ; Gómez R; Leal M; Pion M; Muñoz-Fernández MA
    AIDS; 2013 Aug; 27(13):2053-8. PubMed ID: 23612005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialyl alpha(2-->3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers.
    Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4405-8. PubMed ID: 18639456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.